Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag

Journal of Virology
Hongtao ZhangLiang Qiao

Abstract

Mucosal surfaces are the primary portals for human immunodeficiency virus (HIV) transmission. Because systemic immunization, in general, does not induce effective mucosal immune responses, a mucosal HIV vaccine is urgently needed. For this study, we developed papillomavirus pseudoviruses that express HIV-1 Gag. The pseudoviruses are synthetic, nonreplicating viruses, yet they can produce antigens for a long time in the immune system. Here we show that oral immunization of mice by the use of papillomavirus pseudoviruses encoding Gag generated mucosal and systemic Gag-specific cytotoxic T lymphocytes that effectively lysed Gag-expressing target cells. Furthermore, the pseudoviruses generated Gag-specific gamma interferon-producing T cells and serum immunoglobulin G (IgG) and mucosal IgA. In contrast, oral immunization with plasmid DNA encoding HIV-1 Gag did not induce specific immune responses. Importantly, oral immunization with the pseudoviruses induced Gag-specific memory cytotoxic T lymphocytes and protected mice against a rectal mucosal challenge with a recombinant vaccinia virus expressing HIV-1 Gag. Thus, papillomavirus pseudoviruses encoding Gag are a promising mucosal vaccine against AIDS.

References

Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R KirnbauerJ T Schiller
Jan 1, 1991·Journal of Acquired Immune Deficiency Syndromes : JAIDS·A S Bourinbaiar, D M Phillips
May 14, 1988·Lancet·J M MathijsA L Cunningham
Mar 1, 1989·The Journal of Infectious Diseases·C H FoxA S Fauci
Jul 1, 1987·Molecular and Cellular Biology·T R FuerstB Moss
Mar 1, 1988·Annals of Internal Medicine·R J PomerantzM S Hirsch
Jul 23, 1987·Nature·B D WalkerR T Schooley
Jan 1, 1995·Nature Medicine·S Rowland-JonesT Corrah
Jun 20, 1995·Proceedings of the National Academy of Sciences of the United States of America·P A MossJ I Bell
Jan 1, 1997·Springer Seminars in Immunopathology·G PantaleoA S Fauci
Apr 1, 1997·Microbial Pathogenesis·C DupuyP Coursaget
Jul 21, 1997·Virology·M MüllerL Gissmann
Dec 1, 1996·Seminars in Cancer Biology·J T Schiller, D R Lowy
Jan 7, 1998·Immunological Reviews·P GoulderA McMichael
Apr 4, 1998·Nucleic Acids Research·A Touze, P Coursaget

❮ Previous
Next ❯

Citations

Mar 12, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yiqi Seow, Matthew J Wood
Jul 27, 2007·Tuberculosis·Yoshikazu YukiHiroshi Kiyono
Dec 23, 2006·Expert Review of Vaccines·Wolfgang Jechlinger
Sep 3, 2009·Expert Review of Vaccines·Charani Ranasinghe, Ian A Ramshaw
Dec 17, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shari N GordonGenoveffa Franchini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.